AI-generated summary
The authors report an open study of 13 female patients with drug-resistant depression and comorbid borderline personality disorder who added six weeks of bright white light therapy (10,000 lux) to their antidepressants. Using several depression rating scales, they report significant improvement, but they caution that the open design limits how confidently the results can be interpreted.
- Participants
- 13
- Who or what was studied
- Female patients with drug-resistant depressive episodes and comorbid borderline personality disorder who had not improved after six weeks of antidepressants
- Limits stated in the abstract
- The study was open, with no control group, and the authors state the results must be interpreted with caution.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Phototherapy, Lux. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.